期刊文献+
共找到627篇文章
< 1 2 32 >
每页显示 20 50 100
Protective effect of Liangxue Huayu decoction on human retinal pigment epithelial cell(ARPE-19)injury induced by hypoxia through autophagy pathway
1
作者 Han-Ran Zheng Yi-Tong Lin +4 位作者 Sheng Chen Zi-Yang Chen Jun-Chang Cao Zhao-Da Ye Yan-Hong Hu 《Pharmacology Discovery》 2024年第1期44-50,共7页
Background:Exploring the protective mechanism of the Liangxue Huayu(LXHY)decoction on human retinal pigment epithelial(RPE)cells induced by hypoxia through the autophagy pathway.Methods:The appropriate LXHY decoction ... Background:Exploring the protective mechanism of the Liangxue Huayu(LXHY)decoction on human retinal pigment epithelial(RPE)cells induced by hypoxia through the autophagy pathway.Methods:The appropriate LXHY decoction concentration was determined by CCK-8.ARPE-19 cells were divided into the normal control group(A group),CoCl_(2)group(B group),3-Methyladenine(3-MA)group(treated with 3-MA(the inhibition of autophagy pathway))(C group),blank serum(BS)group(D group),LXHY drug-contained serum(DCS)group(E group),and Rapamycin(RAP)group[treated with LXHY drug-contained serum combined with rapamycin group(the activation of autophagy pathway)](F group).Counting the number of autophagosomes and autolysosomes in each group of cells under transmission electron microscopy.After infection of cells in each group by mRFP-GFP-LC3 fusion protein adenovirus,the strength of autophagic flux was detected.The mRNA expression levels of LC3 and Beclin-1 were detected by Q-PCR.Results:CCK-8 assay results showed that LXHY DCS could inhibit the cell proliferation of ARPE-19 under hypoxia(all P<0.05).As the transmission electron microscopy assay result showed,compared with the normal control group,the number of autolysosomes was significantly increased in the CoCl_(2)group(P<0.05).Compared with CoCl_(2)group,the number of autolysosomes was significantly reduced the 3-Methyladenine group,blank serum group and LXHY drug-contained serum group(all P<0.001).As autophagic flux assay result showed,compared with the normal control group,the level of autophagosomes and autolysosomes were significantly risen in CoCl_(2)group(all P<0.001).Compared with the CoCl_(2)group,the level of autophagosomes and autolysosomes were significantly fell down in 3-Methyladenine group,blank serum group and LXHY drug-contained serum group(all P<0.05).The level of autolysosomes in the LXHY drug-contained serum group was lower than in the blank serum group(P<0.05).Compared with the LXHY drug-contained serum group,the levels of autophagosomes and autolysosomes were signific 展开更多
关键词 liangxue Huayu decoction age-related macular degeneration AUTOPHAGY LYSOSOME AUTOPHAGOSOMES
下载PDF
从清肺凉血化瘀法浅谈痰热壅肺型老年性肺炎的治疗 被引量:4
2
作者 齐莹 张娟 +2 位作者 王春萍 杨传银 徐文刚 《中医临床研究》 2019年第31期113-115,共3页
目的:探讨清肺凉血化瘀法治疗痰热壅肺型老年性肺炎的机制,为老年性肺炎的中医治疗提供新的理论和方法。方法:探讨热邪壅肺、血热、血瘀在老年性肺炎中的作用机制。结果:邪热壅肺、血热、血瘀病机在痰热壅肺型老年性肺炎发病过程中起到... 目的:探讨清肺凉血化瘀法治疗痰热壅肺型老年性肺炎的机制,为老年性肺炎的中医治疗提供新的理论和方法。方法:探讨热邪壅肺、血热、血瘀在老年性肺炎中的作用机制。结果:邪热壅肺、血热、血瘀病机在痰热壅肺型老年性肺炎发病过程中起到重要作用。结论:清肺凉血化瘀法治疗痰热壅肺型老年性肺炎,可以为老年性肺炎的治疗提供新的理论依据和治疗思路,提高临床疗效。 展开更多
关键词 清肺 凉血 化瘀 痰热壅肺 老年性肺炎
下载PDF
Shugan Liangxue Decoction(舒肝凉血方)Down-Regulates Estrogen ReceptorαExpression in Breast Cancer Cells 被引量:1
3
作者 ZHOU Ning HAN Shu-yan +3 位作者 CHEN Yan-zhi ZHOU Fei ZHENG Wen-xian LI Ping-ping 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2018年第7期518-524,共7页
Objective: To observe the effect of Shugan Liangxue Decoction(舒肝凉血方, SGLXD) on estrogen receptor α(ERα) in human breast cancer cells. Methods: The effect of SGLXD(0.85–5.10 mg/m L) on the proliferation... Objective: To observe the effect of Shugan Liangxue Decoction(舒肝凉血方, SGLXD) on estrogen receptor α(ERα) in human breast cancer cells. Methods: The effect of SGLXD(0.85–5.10 mg/m L) on the proliferation of breast cancer cells were evaluated by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide(MTT) assay. The nuclear ERα protein levels in MCF-7, T47 D and ZR-75-1 cells which treated by SGLXD for 24 h were examined by western blot and immunofluorescence assay. MCF-7 and MDA-MB-231 cells were treated by 17β-estradiol(E2) with or without SGLXD, for 24 h, and the E2 targeted genes c-myc and bcl-2 protein product was evaluated by western blot. Results: SGLXD showed dose-dependent inhibition on the proliferation of MCF-7, T47 D and ZR-75-1 cells, but did not inhibit the proliferation of MDA-MB-231 cells. Furthermore, the promotive effect on cell growth induced by E2 was also significantly inhibited by SGLXD treatment. With the treatment of 1.70, 3.40, 5.10 mg/m L SGLXD, the nuclear ERα protein level was reduced to 88.1%, 70.4% and 60.9% in MCF-7 cells, and was decreased to 43.0%, 38.4% and 5.9% in ZR-75-1 cells as compared with the control group. In T47 D cells, the nuclear ERα protein was down-regulated to 51.3% and 4.3% by 3.40 and 5.10 mg/m L SGLXD treatment. The down-regulative effect of SGLXD on nuclear ERα was confirmed by immunofluorescence assay. SGLXD decreased the protein product of c-myc and bcl-2. Conclusions: SGLXD may exhibit selective inhibition effect on the proliferation of ER positive breast cancer cells. SGLXD reduced the nuclear ERα expression and the protein product of E2 target gene c-myc and bcl-2. 展开更多
关键词 breast cancer estrogen receptor Shugan liangxue Decoction estrogen receptor inhibitor
原文传递
Efficacy and safety of Liangxue Jiedu decoction for the treatment of progressive psoriasis vulgaris: a multicenter, randomized, controlled study 被引量:3
4
作者 Sun Liyun Li Tiantian +12 位作者 Zhou Dongmei Yang Xiumin Tian Jing Zhao Junying Xu Wei He Yanling Liu Fang Tong Chunguan Chu Xiaoling Dai Ling Zhu Wei Xu Xuying Wang Ping 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2020年第2期296-304,共9页
OBJECTIVE: To determine the clinical efficacy and safety of Liangxue Jiedu decoction(LJD) for the treatment of progressive psoriasis vulgaris and to provide the basis for the development of a standardized treatment pr... OBJECTIVE: To determine the clinical efficacy and safety of Liangxue Jiedu decoction(LJD) for the treatment of progressive psoriasis vulgaris and to provide the basis for the development of a standardized treatment protocol for psoriasis vulgaris.METHODS: In this multicenter, randomized, controlled study, patients with blood-heat type psoriasis were randomly assigned to receive either Chinese herbal medicine(LJD;treatment group) or Western Medicine(cetirizine hydrochloride, vitamin C, and vitamin B complex;control group). Psoriasis Area and Severity Index(PASI) scores were calculated in addition to the number of patients who achieved ≥ 50% or ≥ 75% improvement in PASI score from baseline. The change in symptoms of Chinese medicine(color of rash, burning sensation,itchiness, severity of irritation, and anger) was evaluated and safety was assessed as adverse events and laboratory analysis. t test, independent sample non-parametric test and χ2 test were used to analyze the results.RESULTS: A total of 238 participants were included in the study [treatment group, n = 122(PP analysis117);control group, n = 116(PP analysis 104)]. LJD treatment was associated with a significant improvement in skin lesions and symptoms com-pared with Western Medicine treatment. At the end of the 8-week treatment period, 23.77%(PP analysis 24.79%) of patients in the treatment group had achieved PASI75 and 57.38%(PP analysis 58.97%)had achieved PASI50;the corresponding figures in the control group were 9.48%(9.62%) and 25.00%(25.00%), respectively. The between-group differences were statistically significant(P < 0.05).CONCLUSION: Treatment of psoriasis vulgaris of the blood-heat type using LJD was associated with significantly better outcomes compared with those achieved using standard Western Medicine. 展开更多
关键词 Psoriasis vulgaris Blood heat Treatment outcome SAFETY liangxue Jiedu decoction
原文传递
A model for anticancer surveillance was pharmacologically developed to evaluate vitality principle in breast cancer rats
5
作者 Liu Jinyu Zhang Mengyang +15 位作者 Zhao Xin Ge Shasha Li Shuang Peng Lin Mu Yuxue Chen Chen Li Xiaoya Zhang Rui Feng Xuanye Deng Bo Jia Liqun Lin Yulin Wang Yueqi Cheng Zhiqiang TaeHoo Yi Cai Dayong 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2018年第6期823-833,共11页
OBJECTIVE: To evaluate vitality principle in breast cancer rats by pharmacologically developing a model for anticancer surveillance.METHODS: The breast cancer in rats was replicated with 7,12-Dimethylbenz[a]anthracene... OBJECTIVE: To evaluate vitality principle in breast cancer rats by pharmacologically developing a model for anticancer surveillance.METHODS: The breast cancer in rats was replicated with 7,12-Dimethylbenz[a]anthracene(DMBA, i.g.,100 mg/kg) at d_(001). The anticancer surveillance was defined as the intervals between the primary sensitization and the first challenge stirred with complete Freund's adjuvant(CFA), the various intervals(k = 0.80) were dominated from d_(025)(600.00 h) to d_(095)(2288.82 h). The optimal surveillant status was confirmed with the median effective interval(EI_(50))from tumor volume regressive curve, for developing the pharmacodynamic model. The tumor and tumor infiltrating lymphocyte histopathology was used to confirm the immune surveillance being affected with CFA in breast cancer tumorigenesis.The availability of this model was confirmed with Shugan Liangxue prescription(SLP), from the vitality principle, and assured further from interleukin-12 levels.RESULTS: The regressive curve was set up between the intervals and tumor volumes, the EI_(50) in SLP-treated rats(1475.00 h, Y_(SLP)= 0.1026 +0.8780/[1 + 10^(27.1425-8.565x)]) was postponed, which was 1.87 multiple of the EI_(50) in CFA rats(791.40 h, y =-0.0525 + 0.9452/[1 + 10^(30.4870-10.52x)], so did prepone the curve between the intervals and the immunological biomarker, serum interleukin-12 levels, the EI_(50) in SLP-treated rats(744.90 h, Y_(SLP)=-0.0145 + 0.7455/[1 + 10^(52.09636-18.13x)]) be 0.78 multiple of the EI_(50) in CFA rats(960.10 h, Y_(CFA)= 0.2460 + 0.7270/[1 + 10^(-67.1546 +22.52x)]), this immunological action being mediated the anticancer prognosis. Tumor histology was confirmed the more tumor infiltrating lymphocytes activated in SLP rats with CFA stirred immunity than rats only received CFA.CONCLUSION: The model for anticancer surveillance was pharmacologically established as the optimal interval(791.40 h) between the primary sensitization and the first challenge stirred with complete Freund's adjuvant. This available 展开更多
关键词 BREAST cancer PHARMACOLOGY Drug screening assays antitumor Freund's ADJUVANT Shugan liangxue prespriction
原文传递
Clinical Studies on Liangxue Piyan Granule No.2 in Treatment of Psoriasis
6
作者 毛舒和 秦建中 +1 位作者 李颖奎 辛红 《Chinese Journal of Integrative Medicine》 SCIE CAS 1997年第4期261-263,共3页
Objective: To evaluate the therapeutic mechanism of Liangxue Piyan Granule No. 2 (LPG, on psoriasis. Methods: Ninety six patients with psoriasis were treated with LPG, another 32 patients treated with Fufang Qingdai ... Objective: To evaluate the therapeutic mechanism of Liangxue Piyan Granule No. 2 (LPG, on psoriasis. Methods: Ninety six patients with psoriasis were treated with LPG, another 32 patients treated with Fufang Qingdai Capsule (FQC,) were taken as control; clinical comparison was done with experimental studies. Results: The total effective rate of LPG group was 84. 7%, that of the control 71. 9 %, there was no significant difference (P < 0. 05). However, the recurrence rate of LPG group (3. 6 % ) was significantly lower than that of the control (21. 7 % ), P < 0. 01. Conclusions: LPG could modulate the immune function of the body, by inhibiting directly the proliferation of epidermal cells and the production of interleukin-6. 展开更多
关键词 liangxue Piyan Granule No. 2 PSORIASIS keratin cell INTERLEUKIN-6
原文传递
Efficacy of Liangxue Guyuan decoction(凉血固元汤)on radiation-induced intestinal injury in rats via the toll-like receptor 4/myeloid differentiation primary response 88/nuclear factor-kappa B pathway 被引量:2
7
作者 WANG Yuguo DOU Yongqi +2 位作者 FENG Jian XU Chengyong WANG Qian 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2021年第2期254-261,共8页
OBJECTIVE:To evaluate the efficacy of Liangxue Guyuan decoction(凉血固元汤,LGD)on radiation-induced intestinal injury in rats,and the possible underlying mechanism of action.METHODS:A total of 255 male Sprague-Dawley ... OBJECTIVE:To evaluate the efficacy of Liangxue Guyuan decoction(凉血固元汤,LGD)on radiation-induced intestinal injury in rats,and the possible underlying mechanism of action.METHODS:A total of 255 male Sprague-Dawley rats were used.15 rats were assigned to the control group and the remaining 240 rats were exposed to a^(60)Co source at a dose of 11 Gy.Irradiated rats were randomly divided into model,dexamethasone(DXM),low-dose LGD(LGDl),and high-dose LGD(LGDh)groups and treated for 11 d.The survival rate,weight of body,intestinal pathology and the expression of toll-like receptor 4(TLR4),myeloid differentiation primary response 88(MyD88),and nuclear`factor-kappa B(NF-κB)were recorded.RESULTS:Radiation reduced the survival rate and weight of rats,destroyed the intestinal structure,induced an inflammatory reaction,and increased both protein and mRNA expression of TLR4,MyD88,and NF-κB in ileum.However,LGDh increased the survival rate,inhibited weight loss,alleviated inflammation and improve the expression of TLR4 pathway.CONCLUSIONS:LGD increased the survival rate and inhibit weight loss of irradiated rats,and reduced inflammation and intestinal injury.The underlying mechanism may involve regulation of the TLR4/MyD88/NF-κB pathway. 展开更多
关键词 radiation intestinal injuries toll-like receptor 4 myeloid differentiation factor 88 NF-kappa B liangxue Guyuan decoction
原文传递
A study of ultrasonography for the treatment of Qingre Liangxue decoction on blood-heat psoriasis
8
作者 Jia-Yan Li Li-Li Ma Yi-Miao Fang 《Clinical Research Communications》 2022年第4期1-5,共5页
Objective:The clinical effectiveness of blood-heat psoriasis treated by Qingre Liangxue decoction and ultrasound imaging changes of lesions was observed.Methods:Patients with blood-heat psoriasis were selected and ran... Objective:The clinical effectiveness of blood-heat psoriasis treated by Qingre Liangxue decoction and ultrasound imaging changes of lesions was observed.Methods:Patients with blood-heat psoriasis were selected and randomly grouped into two groups:the treatment group taking the Qingre Liangxue decoction orally,the control group taking the Compound Glycyrrhizin Tablets orally,both groups applying topical emollient lotion for a 12-week treatment period.Ultrasound images of target lesions and healthy skin were collected at different treatment times.Results:The epidermal thickness thought,the dermal density incremented as well as the subepidermal low-echogenic band(SLEB)width narrowed in both groups during the treatment.Conclusion:Qingre Liangxue decoction has signified efficiency in the treatment of blood-heat psoriasis,and high-frequency ultrasound has the advantages of non-invasive,timely and objective in the evolution. 展开更多
关键词 Qingre liangxue decoction high-frequency ultrasonography epidermal thickness dermal density subepidermal low-echogenic band
下载PDF
Liangxue Xiaoban decoction and its disassembled prescriptions ameliorate psoriasis-like skin lesions induced by imiquimod in mice via T cell regulation
9
作者 Feifei Tang Shuling Liu +2 位作者 Fafeng Cheng Qingguo Wang Xueqian Wang 《Journal of Traditional Chinese Medical Sciences》 CAS 2022年第4期409-419,共11页
Objective:To explore the therapeutic capacity of the Liangxue Xiaoban(LXXB)decoction and its disassembled prescriptions in the modulation of T cell subsets and recurrence-related indexes of psoriasis using a psoriasis... Objective:To explore the therapeutic capacity of the Liangxue Xiaoban(LXXB)decoction and its disassembled prescriptions in the modulation of T cell subsets and recurrence-related indexes of psoriasis using a psoriasis-like mouse model.Methods:The psoriasis model was generated by the treatment of BALB/c mice(n=48)with imiquimod.Mice were divided into six groups:control,psoriasis model,tripterygium glycosides,LXXB decoction,Liangxue decoction,and Qingqi decoction.After the intervention period,the interleukin(IL)-17A,IL-22,and interferon-γ levels in mice were examined and hematoxylin and eosin staining was conducted to determine pathological changes in the skin tissues.T cell subset changes in the skin-draining lymph nodes were analyzed using flow cytometry,and the expression levels of the associated transcription factors and recurrence-related indexes in the skin tissues were determined using a polymerase chain reaction.Results:LXXB decoction attenuated the levels of CD8^(+)T,Th17,and Th1 cells and induced an increase in the Th2 and Treg cell levels.The disassembled prescriptions promoted or inhibited specific subsets of T cells to improve the symptoms of psoriasis.Notably,the LXXB and Liangxue decoctions suppressed the expression of IL-22 at both the gene and protein levels and restored the CD103 and IL-15 expressions in the skin tissue to the normal range.Conclusion:LXXB decoction exerted significant immunoregulatory effects on T cell subsets and improved the recurrence-related indexes.Interestingly,the Liangxue prescription appeared to have a therapeutic advantage in terms of Th17 modulation and psoriasis recurrence,while the Qingqi prescription performed better in Treg immunoregulation. 展开更多
关键词 PSORIASIS T cells Recurrence liangxue Xiaoban decoction Disassembled prescription Tripterygium glycoside
下载PDF
Mechanism of Liangxue Huayu decoction in treatment of age-related macular degeneration based on network pharmacology and clinical validation
10
作者 Zi-Yang Chen Ying-Ying Lin +3 位作者 Yi-Huang Zheng Fa-Jie Ke Sheng Chen Yan-Hong Hu 《Drug Combination Therapy》 2022年第3期1-7,共7页
Background:This paper investigates the mechanism of Liangxue Huayu decoction treating age-related macular degeneration through network pharmacology and clinical verification.Methods:The potential targets of Liangxue H... Background:This paper investigates the mechanism of Liangxue Huayu decoction treating age-related macular degeneration through network pharmacology and clinical verification.Methods:The potential targets of Liangxue Huayu decoction were retrieved by the BATMAN-TCM database,and age-related macular degeneration-related disease targets were collected using the OMIM,GeneCards,and CTD databases.The intersection of targets for Liangxue Huayu decoction for age-related macular degeneration was performed using the online tool Venny2.1.0.Protein-protein interaction network was drawn using the String database.And core targets were obtained with the CytoNCA plugin.The gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed using the Metascape database.Finally,targets of Liangxue Huayu decoction for age-related macular degeneration were identified in clinical research.Results:In this study,832 potential action targets and 9,475 age-related macular degeneration-related disease targets were screened,and 575 intersection targets of Liangxue Huayu decoction and age-related macular degeneration were obtained.Protein-protein interaction network analysis showed that 15 core targets include chemokine 8,interleukin 1,histone deacetylase 2,estrogen receptor 2,and glutamate ionotropic receptor NMDA type subunit 1,et al.Gene ontology enrichment analysis included 2,727 biological processes,434 molecular functions,and 206 cellular components.Kyoto Encyclopedia of Genes and Genomes enrichment analysis selected 107 signaling pathways.Clinical validation showed that peripheral blood chemokine 8 and interleukin 1 levels were significantly lower after age-related macular degeneration patients compared with before treatment,and the difference was statistically significant(t chemokine 8=12.684,t interleukin 1=11.405,all P<0.001).Conclusion:By treating age-related macular degeneration with multiple targets and multiple pathways,Liangxue Huayu decoction can down-regulate the expression of inflammatory factors an 展开更多
关键词 liangxue Huayu decoction age-related macular degeneration network pharmacology INTERLEUKIN-1Β chemokines 8
下载PDF
Effect of Simiao Liangxue Granule on Acute Gouty Arthritis in Rats
11
作者 Chunli TANG Jiangcun WEI +6 位作者 Xiumei MA Guangli LU Yusheng HUANG Sen LIANG Ling CHEN Ying YANG Bihua NONG 《Medicinal Plant》 CAS 2021年第2期60-62,66,共4页
[Objectives]To study the anti-inflammatory effect of Simiao Liangxue granule on the rats with acute gouty arthritis(AGA).[Methods]A total of 60 male SD rats were randomly divided into 6 groups with 10 rats in each gro... [Objectives]To study the anti-inflammatory effect of Simiao Liangxue granule on the rats with acute gouty arthritis(AGA).[Methods]A total of 60 male SD rats were randomly divided into 6 groups with 10 rats in each group.The rats in the colchicine group were intragastrically administered with 0.65 mg/kg colchicine,and the rats in low,medium and high dose groups of Simiao Liangxue granule were intragastrically administered with Simiao Liangxue granule with mass concentration of 0.4,0.8 and 1.6 g/kg,respectively.The rats in the normal control group and the model group were given the same amount of normal saline for 7 d,and the acute gouty arthritis model was prepared 1 h after administration on the 5th d.At the end of the experiment,the degree of joint swelling and joint inflammation index,the content of interleukin-1β,tumor necrosis factor-a and cyclooxygenase-2 in articular cartilage,and the content of interleukin-8,NO and UA in serum of rats were measured,and the histomorphological observation was performed.[Results]Compared with the normal control group,the joints of rats were swollen to different degrees,the inflammation score was significantly increased,and the content of IL-1β,TNF-αand COX-2 in the soft tissue of the joints was significantly increased in each group(P<0.05);compared with the model group,the joint swelling degree and inflammation score of rats in the colchicine group and Simiao Liangxue granule group were significantly decreased,the content of IL-1β,TNF-αand COX-2 in the joint soft tissue was also significantly decreased(P<0.05),and the indexes of each dose group of Simiao Liangxue granule were similar to those of the colchicine group;compared with the normal control group,the content of IL-8,NO and UA in the joint soft tissue of rats was significantly increased in each group(P<0.05);compared with the model group,the content of all indexes in joint soft tissue of rats in normal control group,colchicine group and Simiao Liangxue granule group were significantly decreased(P<0.05);the content 展开更多
关键词 Simiao liangxue granule Acute gouty arthritis RAT Anti-inflammatory effect
下载PDF
关于提高脑血管疾病疗效难点的思考 被引量:608
12
作者 王永炎 《中国中西医结合杂志》 CAS CSCD 北大核心 1997年第4期195-196,共2页
关于提高脑血管疾病疗效难点的思考王永炎围绕着脑血管疾病发病率的增高,及生物学界对脑科学研究的进展,世界上对脑血管疾病基础和临床的研究愈加深入,包括中医学在脑血管病的防治方面也显示出我国独特的学术优势,并在国际上逐渐产... 关于提高脑血管疾病疗效难点的思考王永炎围绕着脑血管疾病发病率的增高,及生物学界对脑科学研究的进展,世界上对脑血管疾病基础和临床的研究愈加深入,包括中医学在脑血管病的防治方面也显示出我国独特的学术优势,并在国际上逐渐产生一定的影响。脑血管疾病以脑梗塞和... 展开更多
关键词 脑血管疾病 疗效 中医药疗法
下载PDF
凉血通瘀中药治疗脑出血急性期168例疗效观察 被引量:38
13
作者 过伟峰 张兰坤 +13 位作者 吴勉华 李国春 周学平 叶放 袁园 全亚萍 陈顺中 王敬卿 赵扬 邵凤扬 陈隐漪 顾锡镇 王永生 路楷 《北京中医药大学学报》 CAS CSCD 北大核心 2012年第9期603-606,619,共5页
目的评价凉血通瘀中药治疗脑出血急性期的临床疗效。方法将337例患者随机分为治疗组168例和对照组169例,2组均采用西医内科常规治疗,治疗组同时服用凉血通瘀中药,疗程均为21 d。疗程结束后分别统计并比较2组综合疗效、中风病类诊断评分... 目的评价凉血通瘀中药治疗脑出血急性期的临床疗效。方法将337例患者随机分为治疗组168例和对照组169例,2组均采用西医内科常规治疗,治疗组同时服用凉血通瘀中药,疗程均为21 d。疗程结束后分别统计并比较2组综合疗效、中风病类诊断评分、脑出血吸收情况、脑水肿分级及格拉斯哥预后结果(GOS)评分。结果治疗组总有效率88.0%,高于对照组的77.5%(P<0.05)。2组治疗后中风病类诊断评分及GOS评分均较治疗前显著下降(P<0.01),且治疗组优于对照组(P<0.05或P<0.01)。结论结合凉血通瘀中药治疗脑出血急性期能显著提高临床疗效,改善预后。 展开更多
关键词 脑出血急性期 凉血通瘀方 临床研究 格拉斯哥预后结果评分
原文传递
“辨血为主,从血论治”规范化方药辨证治疗寻常型银屑病研究 被引量:34
14
作者 陈维文 周冬梅 +10 位作者 王萍 孙丽蕴 白彦萍 黄尧洲 史飞 贾力 涂平 张广中 张苍 邓丙戌 王莒生 《中华中医药杂志》 CAS CSCD 北大核心 2015年第10期3614-3618,共5页
目的:评价前期制定的中药内服方案治疗寻常型银屑病的临床疗效及安全性。方法:轻度银屑病患者被辨证分为血热证组、血燥证组和血瘀证组,每个证型均入组120例,按2∶1比例随机分为中药内服治疗组和安慰剂对照组,疗程8周,采用PASI评分改善... 目的:评价前期制定的中药内服方案治疗寻常型银屑病的临床疗效及安全性。方法:轻度银屑病患者被辨证分为血热证组、血燥证组和血瘀证组,每个证型均入组120例,按2∶1比例随机分为中药内服治疗组和安慰剂对照组,疗程8周,采用PASI评分改善率作为评价标准。结果:统计病例350例,中药内服治疗组在血热证组的总有效率为69.23%,血燥证组的总有效率为67.09%,血瘀证组的总有效率为56.41%,但只有在血燥证组中中药内服治疗组优于安慰剂对照组(P<0.05)。中药内服治疗组与安慰剂对照组均无严重不良反应发生。结论:中药内服治疗寻常型银屑病安全、有效,但不同证型的疗效不相同。 展开更多
关键词 寻常型银屑病 血热证 血燥证 血瘀证 凉血解毒汤 养血解毒汤 活血解毒汤 多中心随机对照研究
原文传递
中药舒肝凉血方改善乳腺癌患者潮热的临床研究 被引量:32
15
作者 孙红 薛冬 +2 位作者 高非 欧阳涛 李萍萍 《中国中西医结合杂志》 CAS CSCD 北大核心 2009年第1期30-33,共4页
目的观察中药舒肝凉血方对服用三苯氧胺的乳腺癌患者潮热的改善情况。方法选择2004年10月—2006年11月乳腺癌诊断明确,服用三苯氧胺(他莫西芬tamoxifen,TAM)出现潮热症状的患者73例,随机分为治疗组(37例)和对照组(36例),治疗组予中药舒... 目的观察中药舒肝凉血方对服用三苯氧胺的乳腺癌患者潮热的改善情况。方法选择2004年10月—2006年11月乳腺癌诊断明确,服用三苯氧胺(他莫西芬tamoxifen,TAM)出现潮热症状的患者73例,随机分为治疗组(37例)和对照组(36例),治疗组予中药舒肝凉血方,对照组予安慰剂。观察潮热及睡眠改善情况。以治疗前1周每日平均潮热次数及睡眠情况作为基线。采用国际认可的Kupperman评分方法,比较治疗前后潮热及睡眠改善情况。结果可评价病例66例,治疗组33例,对照组33例。潮热症状减轻情况:治疗组潮热症状消失5例(15.2%),减轻14例(42.4%),无变化14例(42.4%);对照组无患者症状消失,减轻10例(30.3%),无变化23例(69.7%)。两组比较,差异有统计学意义(P=0.012)。睡眠改善情况:治疗组睡眠改善21例(63.6%),无变化12例(36.4%);对照组睡眠改善13例(39.4%),无变化20例(60.6%)。两组比较,差异有统计学意义(P=0.002)。结论中药舒肝凉血方可减轻服用三苯氧胺乳腺癌患者的潮热症状并改善睡眠情况。 展开更多
关键词 舒肝凉血方 乳腺癌 潮热 睡眠状况
下载PDF
凉血地黄汤联合消痔栓治疗混合痔术后并发症疗效观察及对创面愈合、炎症因子的影响 被引量:27
16
作者 王东宏 胡响当 刘洁 《湖南中医药大学学报》 CAS 2022年第3期465-470,共6页
目的观察凉血地黄汤联合消痔栓治疗混合痔术后患者出血、疼痛、肛门水肿疗效观察及对创面愈合、炎症因子的影响。方法选取2020年1月至12月,新疆医科大学附属中医医院收治的160例混合痔术后患者,随机分为对照组和观察组,各80例。对照组... 目的观察凉血地黄汤联合消痔栓治疗混合痔术后患者出血、疼痛、肛门水肿疗效观察及对创面愈合、炎症因子的影响。方法选取2020年1月至12月,新疆医科大学附属中医医院收治的160例混合痔术后患者,随机分为对照组和观察组,各80例。对照组给予常规护理、生理盐水、消痔栓,观察组在对照组基础上给予凉血地黄汤,治疗14 d。比较两组患者术后第2、7、14天出血、疼痛、肛门水肿的变化及治疗前后两组患者临床疗效、血液流变学指标(全血黏度、血浆黏度、红细胞聚集指数)及创面愈合相关指标[血清表皮生长因子(epidermal growth factor,EGF)、转化生长因子-β(transforming growth factor-beta,TGF-β)、Ⅰ型胶原蛋白(collagenⅠ,COL-Ⅰ)水平及炎症因子肿瘤坏死因子-ɑ(tumor necrosis factor,TNF-ɑ)、白细胞介素-6(interleukin-6,IL-6)、白细胞介素-8(interleukin-8,IL-8)]水平的差异性及创面愈合时间差异。结果治疗后观察组总有效率(98.75%)高于对照组(92.50%),差异无统计学意义(P>0.05)。术后第7天,两组出血、疼痛评分均明显低于术后第2天(P<0.05);观察组水肿评分明显低于术后第2天(P<0.05);对照组水肿评分与术后第2天比较,差异无统计学意义(P>0.05)。术后第14天,两组出血、疼痛评分均明显低于术后第7天(P<0.05);观察组水肿评分明显低于术后第7天(P<0.05);对照组水肿评分与术后第7天比较,差异无统计学意义(P>0.05)。术后第2天,两组出血、疼痛、水肿评分比较,差异无统计学意义(P>0.05)。术后第7天,观察组疼痛评分低于对照组(P<0.05)。术后第7、14天,观察组出血、水肿评分均明显低于同期对照组(P<0.05)。术后第14天,两组疼痛评分比较,差异无统计学意义(P>0.05)。治疗后,两组患者全血黏度、血浆黏度、红细胞聚集指数、TNF-ɑ、IL-6、IL-8水平较治疗前均下降,且观察组低于对照组(P<0.05);治疗后两组患者EGF、TGF-β 展开更多
关键词 凉血地黄汤 混合痔 术后并发症 血液流变学 炎症因子 创面愈合
下载PDF
凉血地黄汤加减对混合痔术后创面愈合时间的影响及其机制研究 被引量:27
17
作者 查德华 张玉玲 +2 位作者 汪伟 王乐炜 沈瑜 《安徽中医药大学学报》 2020年第4期17-20,共4页
目的观察凉血地黄汤加减对混合痔术后患者创面愈合及并发症的影响,并探讨其促进创面愈合的作用机制。方法将80例混合痔术后患者,采用随机数字表法分为观察组和对照组,每组40例。对照组予抗感染、中药熏洗及换药等常规治疗,观察组在对照... 目的观察凉血地黄汤加减对混合痔术后患者创面愈合及并发症的影响,并探讨其促进创面愈合的作用机制。方法将80例混合痔术后患者,采用随机数字表法分为观察组和对照组,每组40例。对照组予抗感染、中药熏洗及换药等常规治疗,观察组在对照组基础上予以凉血地黄汤加减口服治疗,疗程7 d。术后1、7 d,对两组患者创面疼痛和水肿程度进行评分;对两组术后并发症进行评估;患者出院后随访两组患者创面愈合时间;术后1、3、7 d分别检测两组患者血清中转化生长因子-β(transforming growth factor-β,TGF-β)、表皮生长因子(epidermal growth factor,EGF)、Ⅰ型胶原蛋白(collagenⅠ,COL-Ⅰ)水平。结果术后7 d,两组患者的疼痛评分、水肿评分均较术后1 d降低,其中两组患者术后1 d与术后7 d疼痛评分差值比较,差异有统计学意义(P<0.05)。两组术后并发症发生率比较,差异有统计学意义(P<0.05)。两组患者创面愈合时间比较,差异有统计学意义(P<0.05)。术后3 d,两组患者TGF-β、EGF及COL-Ⅰ水平均较术后1 d显著升高(P<0.05);术后7 d,两组患者TGF-β、EGF及COL-Ⅰ水平较术后3 d显著升高(P<0.05);术后3、7 d,两组患者TGF-β、EGF及COL-Ⅰ水平比较,差异均有统计学意义(P<0.05)。结论凉血地黄汤加减联合常规治疗可减轻混合痔患者术后疼痛,减少术后并发症,缩短创面愈合时间。其促进创面愈合的机制可能与提高血清TGF-β、EGF、COL-Ⅰ水平有关。 展开更多
关键词 混合痔 凉血地黄汤 转化生长因子-Β 表皮细胞生长因子 Ⅰ型胶原蛋白
下载PDF
凉血生肌方对冠心病介入术后再狭窄及心血管事件的干预 被引量:25
18
作者 崔晓云 吴旸 +6 位作者 农一兵 王轩 郭自强 金刚 宋麦芬 王旭升 林谦 《中国中西医结合杂志》 CAS CSCD 北大核心 2010年第1期30-32,共3页
目的观察凉血生肌方对冠心病介入术后再狭窄及心血管事件发生的干预作用。方法采用随机、单盲的方法,100例冠心病支架植入患者随机分为常规西药对照组和凉血生肌方治疗组,随访至少6个月后并继续随访,以介入术后再狭窄事件及心源性死亡... 目的观察凉血生肌方对冠心病介入术后再狭窄及心血管事件发生的干预作用。方法采用随机、单盲的方法,100例冠心病支架植入患者随机分为常规西药对照组和凉血生肌方治疗组,随访至少6个月后并继续随访,以介入术后再狭窄事件及心源性死亡、急性心肌梗死、复发心绞痛、严重心衰、再介入和冠脉搭桥等不良事件发生率为主要观察指标,观察凉血生肌方对介入术后再狭窄及心血管事件发生的干预作用。结果两组支架内再狭窄、复发心绞痛、估计再狭窄事件的发生率比较,差异无统计学意义(P>0.05),发生估计再狭窄事件的累积风险差异无统计学意义(P>0.05);两组在减少单独心血管事件的发生概率上差异无统计学意义(P>0.05),对于联合心血管事件而言,两组比较差异具有统计学意义(P=0.032),两组患者发生联合心血管事件的累积风险差异具有统计学意义(P=0.036)。结论冠心病介入术后服用凉血生肌方药能降低联合心血管事件发生的概率和累积风险,其益处约在术后6个月显现。 展开更多
关键词 冠状动脉介入术 再狭窄 心血管事件 凉血生肌方
下载PDF
补气凉血汤联合缩宫素治疗产后出血的效果及对炎性因子和氧化应激的影响 被引量:24
19
作者 周玲 孙红 +2 位作者 凌莉 鲁锦 张弘 《中国医药导报》 CAS 2020年第15期100-103,107,共5页
目的探讨补气凉血汤联合缩宫素治疗产后出血的效果及对炎性因子和氧化应激的影响。方法回顾性选取2017年8月~2019年8月苏州大学附属第二医院收治的产后出血患者168例,按不同治疗方法将其分为对照组(n=83,缩宫素治疗)和研究组(n=85,补气... 目的探讨补气凉血汤联合缩宫素治疗产后出血的效果及对炎性因子和氧化应激的影响。方法回顾性选取2017年8月~2019年8月苏州大学附属第二医院收治的产后出血患者168例,按不同治疗方法将其分为对照组(n=83,缩宫素治疗)和研究组(n=85,补气凉血汤联合缩宫素治疗),两组均治疗7 d。比较两组的临床效果,治疗期间出血情况,产后1、3、7 d子宫复旧情况,治疗前后C-反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白介素-8(IL-8)、脂质过氧化物(LPO)、谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)水平及不良反应发生情况。结果研究组临床总有效率高于对照组(P<0.05)。研究组出血时间短于对照组,失血量、后期出血例数少于对照组(P<0.05)。子宫底高度的组间比较、时间点比较及交互作用差异均有统计学意义(P<0.05);组内比较:随着治疗时间延长,两组子宫底高度均逐渐降低(P<0.05);组间比较:产后1 d,两组子宫底高度比较差异无统计学意义(P>0.05);产后3、7 d,研究组子宫底高度低于对照组(P<0.05)。两组治疗后TNF-α、CRP及IL-8水平均低于治疗前,且研究组低于对照组(P<0.05)。两组治疗后LPO水平低于治疗前,且研究组低于对照组(P<0.05);两组治疗后SOD、GSH-Px水平高于治疗前,且研究组高于对照组(P<0.05)。两组不良反应发生率比较差异无统计学意义(P>0.05)。结论补气凉血汤联合缩宫素治疗产后出血的效果确切,子宫复旧情况良好,并可降低血清炎性因子水平,减轻患者氧化应激反应,可为临床治疗提供方案参考。 展开更多
关键词 补气凉血汤 产后出血 缩宫素 临床研究 氧化应激
下载PDF
凉血通瘀方治疗出血性中风急性期瘀热阻窍证患者73例临床观察 被引量:24
20
作者 张兰坤 过伟峰 +4 位作者 徐丹 袁园 李建香 马慧敏 张红新 《中医杂志》 CSCD 北大核心 2012年第1期28-30,44,共4页
目的评价凉血通瘀方治疗出血性中风急性期瘀热阻窍证的临床疗效。方法将135例患者随机分为治疗组73例和对照组62例,两组均采用西医内科常规治疗,治疗组同时服用凉血通瘀方,疗程均为21天。疗程结束后统计并比较两组中风病类诊断评分、瘀... 目的评价凉血通瘀方治疗出血性中风急性期瘀热阻窍证的临床疗效。方法将135例患者随机分为治疗组73例和对照组62例,两组均采用西医内科常规治疗,治疗组同时服用凉血通瘀方,疗程均为21天。疗程结束后统计并比较两组中风病类诊断评分、瘀热阻窍证候积分、综合疗效及脑出血量情况。结果治疗后两组中风病类诊断评分均明显下降,与治疗前比较差异有统计学意义(P<0.01);治疗组治疗后评分明显低于对照组(P<0.05),治疗前后差值明显大于对照组(P<0.01)。两组患者治疗后11天、21天瘀热阻窍证候评分及脑出血量均较治疗前明显下降(P<0.01),治疗后21天与11天比较,证候评分及脑出血量亦明显下降(P<0.01);治疗后21天,两组瘀热阻窍证候评分及脑出血量比较,治疗组明显低于对照组(P<0.01)。治疗组总有效率93.1%,对照组总有效率77.4%,两组比较差异具有统计学意义(P<0.01)。结论凉血通瘀方治疗出血性中风急性期瘀热阻窍证能显著提高疗效,降低中风病类诊断评分及瘀热阻窍证候评分,促进脑出血吸收。 展开更多
关键词 出血性中风 急性期 瘀热阻窍证 凉血通瘀方 疗效评价
原文传递
上一页 1 2 32 下一页 到第
使用帮助 返回顶部